Two men sentenced for leading a $17M Medicare fraud involving unnecessary genetic testing and falsified clinical laboratory enrollment. DOJ and HHS investigations highlight regulatory compliance risks.

The CARE Act proposes a Medicare pilot program to reimburse EMS providers for on-scene care, aiming to reduce unnecessary ER visits and enhance EMS capacity.

The Trump administration announces agreements with Eli Lilly and Novo Nordisk to lower prices and expand Medicare coverage for weight-loss drugs like Wegovy and Zepbound, effective 2026.

Explore Medicare Advantage plans' network restrictions and the CFPB's federal rule preempting state laws banning medical debt credit reporting. Key insights for healthcare insurers and providers.

Elevance Health stock appears undervalued based on discounted cash flow and P/E ratio analyses amid ongoing healthcare reforms and Medicare Advantage shifts. Learn key valuation insights for U.S. health insurance market investors.

Medicare Advantage plans are advancing outcomes by integrating clinical excellence, AI-driven engagement, health literacy, and community partnerships to support holistic member care.

Explore how rural hospitals are adapting to Medicaid cuts and workforce challenges through innovation and targeted strategies to maintain healthcare access in rural America.

Novo Nordisk and Eli Lilly agree to lower GLP-1 drug prices in exchange for expanded Medicare and Medicaid coverage, marking a major shift in U.S. drug pricing and access.

The 2026 Medicare home health final rule release is delayed due to the government shutdown. Proposed 9% reimbursement cuts spark industry-wide concern and strategic responses from key providers and advocacy groups.

CMS issues National Coverage Determination for FDA-approved renal denervation treatment under Coverage with Evidence Development for uncontrolled hypertension in Medicare patients.